T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant ; volume:47 ; number:1 ; day:9 ; month:8 ; year:2024 ; pages:1-7 ; date:12.2024
Neurosurgical review ; 47, Heft 1 (9.8.2024), 1-7, 12.2024
- Creator
-
Onishi, Shumpei
Kojima, Masato
Yamasaki, Fumiyuki
Amatya, Vishwa Jeet
Yonezawa, Ushio
Taguchi, Akira
Ozono, Iori
Go, Yukari
Takeshima, Yukio
Hiyama, Eiso
Horie, Nobutaka
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10143-024-02632-5
- URN
-
urn:nbn:de:101:1-2410291004528.723037185172
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
07.04.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Onishi, Shumpei
- Kojima, Masato
- Yamasaki, Fumiyuki
- Amatya, Vishwa Jeet
- Yonezawa, Ushio
- Taguchi, Akira
- Ozono, Iori
- Go, Yukari
- Takeshima, Yukio
- Hiyama, Eiso
- Horie, Nobutaka
- SpringerLink (Online service)
Other Objects (12)
Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis
Genetically engineered murine NSCs mimic human IDH-mut astrocytoma
Comparison of diagnostic performance of radiologist- and AI-based assessments of T2-FLAIR mismatch sign and quantitative assessment using synthetic MRI in the differential diagnosis between astrocytoma, IDH-mutant and oligodendroglioma, IDH-mutant and 1p/19q-codeleted
Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign
Dual phenotypes in recurrent astrocytoma, IDH-mutant; coexistence of IDH-mutant and IDH-wildtype components: a case report with genetic and epigenetic analysis
Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
Unusual Extra-Axial and Extracranial Recurrence in an IDH Mutant Astrocytoma: A Case Report
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
Sarcomatous transformation of IDH-mutant astrocytoma matching to methylation class oligosarcoma following embolization, a case report
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma
Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis
Genetically engineered murine NSCs mimic human IDH-mut astrocytoma
Comparison of diagnostic performance of radiologist- and AI-based assessments of T2-FLAIR mismatch sign and quantitative assessment using synthetic MRI in the differential diagnosis between astrocytoma, IDH-mutant and oligodendroglioma, IDH-mutant and 1p/19q-codeleted
Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign
Dual phenotypes in recurrent astrocytoma, IDH-mutant; coexistence of IDH-mutant and IDH-wildtype components: a case report with genetic and epigenetic analysis
Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
Unusual Extra-Axial and Extracranial Recurrence in an IDH Mutant Astrocytoma: A Case Report
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
Sarcomatous transformation of IDH-mutant astrocytoma matching to methylation class oligosarcoma following embolization, a case report
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma
Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis
Genetically engineered murine NSCs mimic human IDH-mut astrocytoma
Comparison of diagnostic performance of radiologist- and AI-based assessments of T2-FLAIR mismatch sign and quantitative assessment using synthetic MRI in the differential diagnosis between astrocytoma, IDH-mutant and oligodendroglioma, IDH-mutant and 1p/19q-codeleted
Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign
Dual phenotypes in recurrent astrocytoma, IDH-mutant; coexistence of IDH-mutant and IDH-wildtype components: a case report with genetic and epigenetic analysis
Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
Unusual Extra-Axial and Extracranial Recurrence in an IDH Mutant Astrocytoma: A Case Report
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
Sarcomatous transformation of IDH-mutant astrocytoma matching to methylation class oligosarcoma following embolization, a case report